Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-Lactamases
纳米抗体作为抗 CMY-2 样 C 类 β-内酰胺酶的治疗诊断剂的开发
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.1
doi:10.1128/aac.01499-22
Frédéric Cawez, Paola Sandra Mercuri, Francisco Javier Morales-Yãnez, Rita Maalouf, Marylène Vandevenne, Frederic Kerff, Virginie Guérin, Jacques Mainil, Damien Thiry, Marc Saulmont, Alain Vanderplasschen, Pierre Lafaye, Gabriel Aymé, Pierre Bogaerts, Mireille Dumoulin, Moreno Galleni
